MIGNONE ROBERTO
SEC Form 4 insider trading activity
MIGNONE ROBERTO has filed 18 SEC Form 4 filings (19 transaction rows) across 2 companies, including GH, TEVA, with disclosures dating back to 2025. 17 of those filings fall inside the rolling window. Most recent filing: Oct 22, 2026.
On the most recent filing, MIGNONE ROBERTO is listed as Director at TEVA PHARMACEUTICAL INDUSTRIES LTD. Inside the rolling window, MIGNONE ROBERTO reported no open-market purchases and 4 open-market sales totaling $22.8M in TEVA. The largest disclosed transaction in the window is a sale of 367,600 TEVA shares on Sep 18, 2026, worth $14.4M.
Companies traded
Other insiders at GH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$22.8M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MIGNONE ROBERTO made?
MIGNONE ROBERTO has filed 18 SEC Form 4 filings (19 transaction rows) across 2 companies, including GH, TEVA since 2025.
Which companies does MIGNONE ROBERTO trade?
MIGNONE ROBERTO has filed SEC Form 4 disclosures for 2 companies, including GH, TEVA.
When was MIGNONE ROBERTO's most recent SEC Form 4 filing?
MIGNONE ROBERTO's most recent SEC Form 4 filing on Tracefour is dated Oct 22, 2026.
What is MIGNONE ROBERTO's total buy and sell value in the current window?
Inside the rolling retention window, MIGNONE ROBERTO bought $0 and sold $22.8M based on SEC Form 4 filings.
What was MIGNONE ROBERTO's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 367,600 TEVA shares on 2026-09-18, worth $14.4M, per SEC Form 4 filings.